S149: LONG TERM OUTCOMES OF IFCG REGIMEN FOR FIRSTLINE TREATMENT OF PATIENTS WITH CLL WITH MUTATED IGHV AND WITHOUT DEL(17P)/TP53 MUTATION
| Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2022-06-01
|
| Series: | HemaSphere |
| Online Access: | http://journals.lww.com/10.1097/01.HS9.0000843488.43813.af |
| _version_ | 1827336402213273600 |
|---|---|
| author | N. Jain P. Thompson J. Burger A. Ferrajoli K. Takahashi Z. Estrov G. Borthakur P. Bose T. Kadia N. Pemmaraju K. Sasaki M. Konopleva E. Jabbour N. Garg X. Wang R. Kanagal-Shamanna K. Patel W. Wang S. Wang J. Jorgensen W. Lopez A. Ayala W. Plunkett V. Gandhi H. Kantarjian S. O’Brien M. Keating W. Wierda |
| author_facet | N. Jain P. Thompson J. Burger A. Ferrajoli K. Takahashi Z. Estrov G. Borthakur P. Bose T. Kadia N. Pemmaraju K. Sasaki M. Konopleva E. Jabbour N. Garg X. Wang R. Kanagal-Shamanna K. Patel W. Wang S. Wang J. Jorgensen W. Lopez A. Ayala W. Plunkett V. Gandhi H. Kantarjian S. O’Brien M. Keating W. Wierda |
| author_sort | N. Jain |
| collection | DOAJ |
| first_indexed | 2024-03-07T18:30:01Z |
| format | Article |
| id | doaj.art-736788000a6d49e0b81309f4c276dd92 |
| institution | Directory Open Access Journal |
| issn | 2572-9241 |
| language | English |
| last_indexed | 2024-03-07T18:30:01Z |
| publishDate | 2022-06-01 |
| publisher | Wiley |
| record_format | Article |
| series | HemaSphere |
| spelling | doaj.art-736788000a6d49e0b81309f4c276dd922024-03-02T06:40:22ZengWileyHemaSphere2572-92412022-06-016505110.1097/01.HS9.0000843488.43813.af202206003-00050S149: LONG TERM OUTCOMES OF IFCG REGIMEN FOR FIRSTLINE TREATMENT OF PATIENTS WITH CLL WITH MUTATED IGHV AND WITHOUT DEL(17P)/TP53 MUTATIONN. Jain0P. Thompson1J. Burger2A. Ferrajoli3K. Takahashi4Z. Estrov5G. Borthakur6P. Bose7T. Kadia8N. Pemmaraju9K. Sasaki10M. Konopleva11E. Jabbour12N. Garg13X. Wang14R. Kanagal-Shamanna15K. Patel16W. Wang17S. Wang18J. Jorgensen19W. Lopez20A. Ayala21W. Plunkett22V. Gandhi23H. Kantarjian24S. O’Brien25M. Keating26W. Wierda271 Leukemia1 Leukemia1 Leukemia1 Leukemia1 Leukemia1 Leukemia1 Leukemia1 Leukemia1 Leukemia1 Leukemia1 Leukemia1 Leukemia1 Leukemia2 Radiology3 Biostatistics4 Hematopathology4 Hematopathology4 Hematopathology4 Hematopathology4 Hematopathology1 Leukemia1 Leukemia5 Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, Houston5 Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, Houston1 Leukemia6 Chao Family Comprehensive Cancer Center, University of California Irvine Medical Center, Orange, United States of America1 Leukemia1 Leukemiahttp://journals.lww.com/10.1097/01.HS9.0000843488.43813.af |
| spellingShingle | N. Jain P. Thompson J. Burger A. Ferrajoli K. Takahashi Z. Estrov G. Borthakur P. Bose T. Kadia N. Pemmaraju K. Sasaki M. Konopleva E. Jabbour N. Garg X. Wang R. Kanagal-Shamanna K. Patel W. Wang S. Wang J. Jorgensen W. Lopez A. Ayala W. Plunkett V. Gandhi H. Kantarjian S. O’Brien M. Keating W. Wierda S149: LONG TERM OUTCOMES OF IFCG REGIMEN FOR FIRSTLINE TREATMENT OF PATIENTS WITH CLL WITH MUTATED IGHV AND WITHOUT DEL(17P)/TP53 MUTATION HemaSphere |
| title | S149: LONG TERM OUTCOMES OF IFCG REGIMEN FOR FIRSTLINE TREATMENT OF PATIENTS WITH CLL WITH MUTATED IGHV AND WITHOUT DEL(17P)/TP53 MUTATION |
| title_full | S149: LONG TERM OUTCOMES OF IFCG REGIMEN FOR FIRSTLINE TREATMENT OF PATIENTS WITH CLL WITH MUTATED IGHV AND WITHOUT DEL(17P)/TP53 MUTATION |
| title_fullStr | S149: LONG TERM OUTCOMES OF IFCG REGIMEN FOR FIRSTLINE TREATMENT OF PATIENTS WITH CLL WITH MUTATED IGHV AND WITHOUT DEL(17P)/TP53 MUTATION |
| title_full_unstemmed | S149: LONG TERM OUTCOMES OF IFCG REGIMEN FOR FIRSTLINE TREATMENT OF PATIENTS WITH CLL WITH MUTATED IGHV AND WITHOUT DEL(17P)/TP53 MUTATION |
| title_short | S149: LONG TERM OUTCOMES OF IFCG REGIMEN FOR FIRSTLINE TREATMENT OF PATIENTS WITH CLL WITH MUTATED IGHV AND WITHOUT DEL(17P)/TP53 MUTATION |
| title_sort | s149 long term outcomes of ifcg regimen for firstline treatment of patients with cll with mutated ighv and without del 17p tp53 mutation |
| url | http://journals.lww.com/10.1097/01.HS9.0000843488.43813.af |
| work_keys_str_mv | AT njain s149longtermoutcomesofifcgregimenforfirstlinetreatmentofpatientswithcllwithmutatedighvandwithoutdel17ptp53mutation AT pthompson s149longtermoutcomesofifcgregimenforfirstlinetreatmentofpatientswithcllwithmutatedighvandwithoutdel17ptp53mutation AT jburger s149longtermoutcomesofifcgregimenforfirstlinetreatmentofpatientswithcllwithmutatedighvandwithoutdel17ptp53mutation AT aferrajoli s149longtermoutcomesofifcgregimenforfirstlinetreatmentofpatientswithcllwithmutatedighvandwithoutdel17ptp53mutation AT ktakahashi s149longtermoutcomesofifcgregimenforfirstlinetreatmentofpatientswithcllwithmutatedighvandwithoutdel17ptp53mutation AT zestrov s149longtermoutcomesofifcgregimenforfirstlinetreatmentofpatientswithcllwithmutatedighvandwithoutdel17ptp53mutation AT gborthakur s149longtermoutcomesofifcgregimenforfirstlinetreatmentofpatientswithcllwithmutatedighvandwithoutdel17ptp53mutation AT pbose s149longtermoutcomesofifcgregimenforfirstlinetreatmentofpatientswithcllwithmutatedighvandwithoutdel17ptp53mutation AT tkadia s149longtermoutcomesofifcgregimenforfirstlinetreatmentofpatientswithcllwithmutatedighvandwithoutdel17ptp53mutation AT npemmaraju s149longtermoutcomesofifcgregimenforfirstlinetreatmentofpatientswithcllwithmutatedighvandwithoutdel17ptp53mutation AT ksasaki s149longtermoutcomesofifcgregimenforfirstlinetreatmentofpatientswithcllwithmutatedighvandwithoutdel17ptp53mutation AT mkonopleva s149longtermoutcomesofifcgregimenforfirstlinetreatmentofpatientswithcllwithmutatedighvandwithoutdel17ptp53mutation AT ejabbour s149longtermoutcomesofifcgregimenforfirstlinetreatmentofpatientswithcllwithmutatedighvandwithoutdel17ptp53mutation AT ngarg s149longtermoutcomesofifcgregimenforfirstlinetreatmentofpatientswithcllwithmutatedighvandwithoutdel17ptp53mutation AT xwang s149longtermoutcomesofifcgregimenforfirstlinetreatmentofpatientswithcllwithmutatedighvandwithoutdel17ptp53mutation AT rkanagalshamanna s149longtermoutcomesofifcgregimenforfirstlinetreatmentofpatientswithcllwithmutatedighvandwithoutdel17ptp53mutation AT kpatel s149longtermoutcomesofifcgregimenforfirstlinetreatmentofpatientswithcllwithmutatedighvandwithoutdel17ptp53mutation AT wwang s149longtermoutcomesofifcgregimenforfirstlinetreatmentofpatientswithcllwithmutatedighvandwithoutdel17ptp53mutation AT swang s149longtermoutcomesofifcgregimenforfirstlinetreatmentofpatientswithcllwithmutatedighvandwithoutdel17ptp53mutation AT jjorgensen s149longtermoutcomesofifcgregimenforfirstlinetreatmentofpatientswithcllwithmutatedighvandwithoutdel17ptp53mutation AT wlopez s149longtermoutcomesofifcgregimenforfirstlinetreatmentofpatientswithcllwithmutatedighvandwithoutdel17ptp53mutation AT aayala s149longtermoutcomesofifcgregimenforfirstlinetreatmentofpatientswithcllwithmutatedighvandwithoutdel17ptp53mutation AT wplunkett s149longtermoutcomesofifcgregimenforfirstlinetreatmentofpatientswithcllwithmutatedighvandwithoutdel17ptp53mutation AT vgandhi s149longtermoutcomesofifcgregimenforfirstlinetreatmentofpatientswithcllwithmutatedighvandwithoutdel17ptp53mutation AT hkantarjian s149longtermoutcomesofifcgregimenforfirstlinetreatmentofpatientswithcllwithmutatedighvandwithoutdel17ptp53mutation AT sobrien s149longtermoutcomesofifcgregimenforfirstlinetreatmentofpatientswithcllwithmutatedighvandwithoutdel17ptp53mutation AT mkeating s149longtermoutcomesofifcgregimenforfirstlinetreatmentofpatientswithcllwithmutatedighvandwithoutdel17ptp53mutation AT wwierda s149longtermoutcomesofifcgregimenforfirstlinetreatmentofpatientswithcllwithmutatedighvandwithoutdel17ptp53mutation |